BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa AE. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements. Int J Mol Sci 2020;22:E130. [PMID: 33374459 DOI: 10.3390/ijms22010130] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou H, Zou J, Shao C, Zhou A, Yu J, Chen S, Xu C. Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway. Pathol Res Pract 2021;230:153749. [PMID: 34959098 DOI: 10.1016/j.prp.2021.153749] [Reference Citation Analysis]
2 Chen HM, MacDonald JA. Network analysis identifies DAPK3 as a potential biomarker for lymphatic invasion and colon adenocarcinoma prognosis. iScience 2021;24:102831. [PMID: 34368650 DOI: 10.1016/j.isci.2021.102831] [Reference Citation Analysis]
3 Dai Y, Zhao W, Yue L, Dai X, Rong D, Wu F, Gu J, Qian X. Perspectives on Immunotherapy of Metastatic Colorectal Cancer. Front Oncol 2021;11:659964. [PMID: 34178645 DOI: 10.3389/fonc.2021.659964] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhou Z, Long H, Xu S, Li F, Cheng Y, Luo H, Gao L. Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways. Front Pharmacol 2022;13:899208. [DOI: 10.3389/fphar.2022.899208] [Reference Citation Analysis]
5 Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci 2021;22:11365. [PMID: 34768795 DOI: 10.3390/ijms222111365] [Reference Citation Analysis]
6 Passardi A, Scarpi E, Ulivi P. Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0. Int J Mol Sci 2021;22:7479. [PMID: 34299099 DOI: 10.3390/ijms22147479] [Reference Citation Analysis]
7 Anghel SA, Ioniță-Mîndrican CB, Luca I, Pop AL. Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review. Cancers (Basel) 2021;13:4965. [PMID: 34638449 DOI: 10.3390/cancers13194965] [Reference Citation Analysis]
8 Deng XH, Li J, Chen SJ, Xie YJ, Zhang J, Cen GY, Song YT, Liang ZJ. Clinical features of intracerebral hemorrhage in patients with colorectal cancer and its underlying pathogenesis. World J Gastrointest Oncol 2021; 13(12): 2180-2189 [DOI: 10.4251/wjgo.v13.i12.2180] [Reference Citation Analysis]
9 Talebi A, Rokni P, Kerachian MA. Transcriptome analysis of colorectal cancer liver metastasis: The importance of long non-coding RNAs and fusion transcripts in the disease pathogenesis. Molecular and Cellular Probes 2022. [DOI: 10.1016/j.mcp.2022.101816] [Reference Citation Analysis]
10 Gilmore TD. NF-κB and Human Cancer: What Have We Learned over the Past 35 Years? Biomedicines 2021;9:889. [PMID: 34440093 DOI: 10.3390/biomedicines9080889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhou M, Wang S, Liu D, Zhou J. LINC01915 Facilitates the Conversion of Normal Fibroblasts into Cancer-Associated Fibroblasts Induced by Colorectal Cancer-Derived Extracellular Vesicles through the miR-92a-3p/KLF4/CH25H Axis. ACS Biomater Sci Eng 2021;7:5255-68. [PMID: 34643375 DOI: 10.1021/acsbiomaterials.1c00611] [Reference Citation Analysis]
12 Moazzendizaji S, Sevbitov A, Ezzatifar F, Jalili HR, Aalii M, Hemmatzadeh M, Aslani S, Gholizadeh Navashenaq J, Safari R, Hosseinzadeh R, Rahmany MR, Mohammadi H. microRNAs: Small molecules with a large impact on colorectal cancer. Biotechnol Appl Biochem 2021. [PMID: 34550619 DOI: 10.1002/bab.2255] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Guo S, Sun Y. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial–Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification. CMAR 2022;Volume 14:1371-84. [DOI: 10.2147/cmar.s345299] [Reference Citation Analysis]
14 Pezeshkian Z, Nobili S, Peyravian N, Shojaee B, Nazari H, Soleimani H, Asadzadeh-Aghdaei H, Ashrafian Bonab M, Nazemalhosseini-Mojarad E, Mini E. Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer. Cancers (Basel) 2021;13:6226. [PMID: 34944846 DOI: 10.3390/cancers13246226] [Reference Citation Analysis]
15 Huang Y, Huang C, Jiang X, Yan Y, Zhuang K, Liu F, Li P, Wen Y. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis. Front Genet 2022;13:816173. [DOI: 10.3389/fgene.2022.816173] [Reference Citation Analysis]
16 Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T. E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Mol Oncol 2021. [PMID: 34890102 DOI: 10.1002/1878-0261.13159] [Reference Citation Analysis]
17 Mori K, Hamada T, Beppu M, Tsuchihashi H, Goto Y, Kume K, Hijioka H, Nishi K, Mishima Y, Sugiura T. Detecting Early-Stage Oral Cancer from Clinically Diagnosed Oral Potentially Malignant Disorders by DNA Methylation Profile. Cancers (Basel) 2022;14:2646. [PMID: 35681626 DOI: 10.3390/cancers14112646] [Reference Citation Analysis]
18 Ilhan N, Bektas I, Susam S, Ozercan IH. Protective effects of rosmarinic acid against azoxymethane-induced colorectal cancer in rats. J Biochem Mol Toxicol 2021;:e22961. [PMID: 34766714 DOI: 10.1002/jbt.22961] [Reference Citation Analysis]
19 Mann R, Gajendran M, Umapathy C, Perisetti A, Goyal H, Saligram S, Echavarria J. Endoscopic Management of Complex Colorectal Polyps: Current Insights and Future Trends. Front Med 2022;8:728704. [DOI: 10.3389/fmed.2021.728704] [Reference Citation Analysis]
20 Grigoletto A, Martinez G, Gabbia D, Tedeschini T, Scaffidi M, Martin S, Pasut G. Folic Acid-Targeted Paclitaxel-Polymer Conjugates Exert Selective Cytotoxicity and Modulate Invasiveness of Colon Cancer Cells. Pharmaceutics 2021;13:929. [PMID: 34201494 DOI: 10.3390/pharmaceutics13070929] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Mahmud KM, Niloy MS, Shakil MS, Islam MA. Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment. Pharmaceutics 2021;13:1295. [PMID: 34452256 DOI: 10.3390/pharmaceutics13081295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin 2022. [PMID: 35472088 DOI: 10.3322/caac.21728] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Shaheen S, Alshammari EM, Mokhtar SH, Alshanwani AR, Toraih EA, Ibrahiem AT, Fawzy MS, Maher SA. PUNISHER rs12318065 C>A transversion: a putative somatic driver mutation for poor prognosis in colon cancer. Biosci Rep 2022;42:BSR20220465. [PMID: 35670784 DOI: 10.1042/BSR20220465] [Reference Citation Analysis]
24 Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi J, John A, Lim YC, Kibria KMK, Mohiuddin AKM, Ming LC, Goh KW, Hadi MA. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers (Basel) 2022;14:1732. [PMID: 35406504 DOI: 10.3390/cancers14071732] [Reference Citation Analysis]
25 Zhou H, Huang S, Shao C, Zou J, Zhou A, Yu J, Xu C, Andreucci E. miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3. Analytical Cellular Pathology 2022;2022:1-15. [DOI: 10.1155/2022/1542117] [Reference Citation Analysis]
26 Li Q, Chen JX, Wu Y, Lv LL, Ying HF, Zhu WH, Xu JY, Zhu WR, Zheng L. The mechanism of FZXJJZ decoction suppresses colorectal liver metastasis via the VDR/TGFβ/Snail1 signaling pathways based on network pharmacology-TCGA data-transcriptomics analysis. J Ethnopharmacol 2021;:114904. [PMID: 34952191 DOI: 10.1016/j.jep.2021.114904] [Reference Citation Analysis]
27 Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-κB signaling in inflammation and cancer. MedComm (2020) 2021;2:618-53. [PMID: 34977871 DOI: 10.1002/mco2.104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liebl MC, Hofmann TG. The Role of p53 Signaling in Colorectal Cancer. Cancers (Basel) 2021;13:2125. [PMID: 33924934 DOI: 10.3390/cancers13092125] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Wei W, Zhao W, Zhang Y. CBX4 Provides an Alternate Mode of Colon Cancer Development via Potential Influences on Circadian Rhythm and Immune Infiltration. Front Cell Dev Biol 2021;9:669254. [PMID: 34222240 DOI: 10.3389/fcell.2021.669254] [Reference Citation Analysis]
30 Wang H, Wang J, Li D, Zhu Z, Pei D. A functional polymorphism within the distal promoter of RUNX3 confers risk of colorectal cancer. Int J Biol Markers. [DOI: 10.1177/17246008211073342] [Reference Citation Analysis]
31 Moshawih S, Lim AF, Ardianto C, Goh KW, Kifli N, Goh HP, Jarrar Q, Ming LC. Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies. Biomolecules 2022;12:878. [DOI: 10.3390/biom12070878] [Reference Citation Analysis]
32 Huang J, Yu S, Ding L, Ma L, Chen H, Zhou H, Zou Y, Yu M, Lin J, Cui Q. The Dual Role of Circular RNAs as miRNA Sponges in Breast Cancer and Colon Cancer. Biomedicines 2021;9:1590. [PMID: 34829818 DOI: 10.3390/biomedicines9111590] [Reference Citation Analysis]